We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the difference between hereditary and acquired risks for Non-Hodgkin's Lymphoma. Learn about genetic influences, risk factors, symptoms, diagnosis, and prevention strategies for NHL.

Non-Hodgkin's Lymphoma (NHL) is a type of blood cancer that affects the lymphatic system, a crucial part of the immune system. While the term 'hereditary' might come to mind when discussing family health history, it's important to clarify that NHL is generally not considered a hereditary disease. This means you cannot directly inherit NHL from your parents. However, having a family history of this condition can increase your risk, and understanding the nuances of genetics, environmental factors, and lifestyle is key to managing and preventing it.
The short answer is no, you cannot inherit Non-Hodgkin's Lymphoma directly from your parents. Hereditary cancers are those caused by gene mutations passed down from parents to children at birth. For NHL, the genetic changes that lead to the disease are typically acquired during a person's lifetime, rather than being present from birth. This distinction is vital for understanding risk and prevention strategies.
While not hereditary, NHL can appear in families. If you have a close relative, such as a parent, sibling, or child, who has had lymphoma, your risk of developing NHL may be slightly higher. However, experts are still researching the exact reasons for this increased risk. It could be due to a combination of factors, including shared genetic predispositions that don't directly cause the disease but might make someone more susceptible, as well as shared environmental exposures and lifestyle habits within a family. It's important to remember that even with a family history, the majority of people will not develop NHL.
All cancers, including NHL, are fundamentally genetic diseases. They arise when cells in the body undergo abnormal genetic changes, or mutations, that disrupt their normal growth, division, and repair processes. These mutations lead to uncontrolled cell proliferation, forming tumors and affecting bodily functions. For NHL, these critical genetic mutations are usually acquired over time. This can happen due to various factors:
Scientists are actively researching the specific genetic mutations associated with NHL to develop more effective diagnostic tools and targeted therapies.
Beyond genetics and family history, several other factors can increase the risk of developing NHL:
The symptoms of NHL can vary depending on the type and location of the affected lymph nodes. Some common signs to watch out for include:
It's important to note that these symptoms can also be caused by less serious conditions. However, if you experience any of these persistently, it's crucial to consult a doctor.
Diagnosing NHL typically involves a combination of methods:
Treatment for NHL depends on the specific type of lymphoma, its stage, the patient's overall health, and their preferences. Common treatment options include:
Since NHL is not hereditary and many causes are acquired, focusing on a healthy lifestyle can help reduce risk:
It is essential to consult a doctor if you experience any persistent symptoms suggestive of lymphoma, such as unexplained swollen lymph nodes, persistent fatigue, fever, night sweats, or significant weight loss. Early detection and diagnosis are crucial for effective treatment and better outcomes. If you have a family history of lymphoma, discuss your concerns with your doctor, who can provide personalized advice and recommend appropriate screening or monitoring.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026